about
Effect of oral administration of Pheretima aspergillum (earthworm) in rats with cerebral infarction induced by middle-cerebral artery occlusionIRES-based vector coexpressing FGF2 and Cyr61 provides synergistic and safe therapeutics of lower limb ischemia.Effect of angiogenesis induced by consecutive intramuscular injections of vascular endothelial growth factor in a hindlimb ischemic mouse modelLonafarnib is a potential inhibitor for neovascularization.SCF(β-TRCP) suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2.Angiopoietin-1 variant reduces LPS-induced microvascular dysfunction in a murine model of sepsisInteractions of PPAR-alpha and adenosine receptors in hypoxia-induced angiogenesis.Angiogenesis is a link between atherosclerosis and tumorigenesis: role of LOX-1.Role of silver nanoparticles (AgNPs) on the cardiovascular system.Therapeutic application of anti-angiogenic nanomaterials in cancers.Therapeutic angiogenesis in ischemic muscles after local injection of fragmented fibers with loaded traditional Chinese medicine.Effects of extracellular matrix density and mesenchymal stem cells on neovascularization in vivo.Increased serum kallistatin levels in type 1 diabetes patients with vascular complicationsThe management of enthusiasm: motives and expectations in cardiovascular medicine.Effects of serum reduction and VEGF supplementation on angiogenic potential of human adipose stromal cells in vitro.Complementary effects of ciclopirox olamine, a prolyl hydroxylase inhibitor and sphingosine 1-phosphate on fibroblasts and endothelial cells in driving capillary sprouting.Total Flavonoids in (TFC) Promotes Angiogenesis and Enhances Cerebral Perfusion in a Rat Model of Ischemic Stroke
P2860
Q24630720-6F4BD42F-8134-4A0F-BC60-B07BAF628F07Q33500964-83297ADA-BFE0-4325-ABA0-DAB99ABE6E6EQ34090901-00020080-8654-4169-AE32-FB6E1DEFF03AQ35324064-E30ADD7D-4DD1-4D2E-B7E5-325B8B9B5F7FQ36118305-1AEBCE55-0D1E-4A91-ACD6-C77B4324FCD9Q36928185-8D40B218-9BE5-47C1-A8CF-47E6F0404243Q37421898-ACE78335-6095-485C-90F1-077B25ADEBE9Q37942011-BC5D1AC3-FF95-4B26-B14D-071B1F491DD8Q38301573-D74EABB5-EFD8-40A0-9076-647BD532B95CQ38805034-1F75BC05-1C21-478F-8AAA-75A6885F31B1Q38852928-508650E2-3390-4EDD-96B6-BDB7DB4D27EEQ39639284-B49F7DA9-273C-4E17-A778-F53F5AB77B47Q42034969-2F709C0F-968F-4C6D-B90B-2F5D1070FE66Q42697998-2CADD9F2-03DC-4AD4-89EA-128F83575D96Q45005578-49BADD33-10D6-4A40-BE98-74884D643C50Q54662271-A2CDEBCD-AC5A-41D8-A73D-EC0BFBCFF253Q58746579-D5D233A2-33CE-493F-8784-DB0142D624FE
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Therapeutic angiogenesis in cardiovascular disease.
@en
Therapeutic angiogenesis in cardiovascular disease.
@nl
type
label
Therapeutic angiogenesis in cardiovascular disease.
@en
Therapeutic angiogenesis in cardiovascular disease.
@nl
prefLabel
Therapeutic angiogenesis in cardiovascular disease.
@en
Therapeutic angiogenesis in cardiovascular disease.
@nl
P2860
P356
P1476
Therapeutic angiogenesis in cardiovascular disease.
@en
P2093
Hilal Al Sabti
P2860
P2888
P356
10.1186/1749-8090-2-49
P5008
P577
2007-11-16T00:00:00Z
P5875
P6179
1013877007